Demars Financial Group, LLC

SEC CIK: 0001723115
Latest filing: Jul 21, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Demars Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 21; Since Q1 2021

Holdings of ABT by Demars Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−2,011−100.0%	Sold out	Holders
Q1 2026	2,011	$206.5K	0.1%	−8−0.4%	Reduced	Holders
Q4 2025	2,019	$253.0K	0.1%	00.0%	Unchanged	Holders
Q3 2025	2,019	$270.4K	0.1%	−302−13.0%	Reduced	Holders
Q2 2025	2,321	$315.7K	0.1%	−321,256−99.3%	Reduced	Holders
Q1 2025	323,577	$2.44K	0.1%	+46,194+16.7%	Added	Holders
Q4 2024	277,383	$2.45K	0.1%	+274,821+10,726.8%	Added	Holders
Q3 2024	2,562	$292.1K	0.1%	−59−2.3%	Reduced	Holders
Q2 2024	2,621	$272.3K	0.1%	−383−12.7%	Reduced	Holders
Q1 2024	3,004	$341.5K	0.2%	−32−1.1%	Reduced	Holders
Q4 2023	3,036	$334.2K	0.2%	−9−0.3%	Reduced	Holders
Q3 2023	3,045	$294.9K	0.2%	+89+3.0%	Added	Holders
Q2 2023	2,956	$322.3K	0.2%	−207−6.5%	Reduced	Holders
Q1 2023	3,163	$320.3K	0.2%	−13−0.4%	Reduced	Holders
Q4 2022	3,176	$348.7K	0.2%	−477−13.1%	Reduced	Holders
Q3 2022	3,653	$354.0K	0.2%	−19−0.5%	Reduced	Holders
Q2 2022	3,672	$399.0K	0.2%	−28,112−88.4%	Reduced	Holders
Q1 2022	31,784	$3.76M	1.9%	+3,109+10.8%	Added	Holders
Q4 2021	28,675	$4.04M	2.1%	+420+1.5%	Added	Holders
Q3 2021	28,255	$3.34M	2.0%	−1,683−5.6%	Reduced	Holders
Q2 2021	29,938	$3.47M	2.1%	+1,241+4.3%	Added	Holders
Q1 2021	28,697	$3.44M	2.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.